Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP564652.RAPutDhdfoQzKTJ-3Hq-SnvHilkWccbSYjyGDizMa6Nbc#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Despite increasing use of 'targeted therapy,' interleukin-2 (IL-2) is unique, because this cytokine can induce long-term remissions in 5% to 7% of patients with metastatic melanoma and renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion evidence source_evidence_literature provenance.
- assertion SIO_000772 21577143 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion wasGeneratedBy ECO_0000203 provenance.